| 000 | 01638 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514232238.0 | ||
| 264 | 0 | _c20051115 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a1568-007X | ||
| 024 | 7 |
_a10.2174/1568007054038210 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLue, L-F | |
| 245 | 0 | 0 |
_aPreventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bCurrent drug targets. CNS and neurological disorders _cJun 2005 |
||
| 300 |
_a249-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _ximmunology |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Vessels _xcytology |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMicroglia _ximmunology |
| 650 | 0 | 4 |
_aPericytes _ximmunology |
| 650 | 0 | 4 |
_aProtein Isoforms _xmetabolism |
| 650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
| 700 | 1 | _aYan, S D | |
| 700 | 1 | _aStern, D M | |
| 700 | 1 | _aWalker, D G | |
| 773 | 0 |
_tCurrent drug targets. CNS and neurological disorders _gvol. 4 _gno. 3 _gp. 249-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568007054038210 _zAvailable from publisher's website |
| 999 |
_c15632922 _d15632922 |
||